Literature DB >> 8431400

ABO blood grouping of bloodstains by sandwich ELISA using monoclonal antibody specific for human red cell band 3.

A Kimura1, T Uda, S Nakashima, H Ikeda, S Yasuda, M Osawa, T Tsuji.   

Abstract

ABO blood grouping of human bloodstains was performed by a sandwich ELISA using a species-specific monoclonal antibody to the amino-terminal cytoplasmic domain of human red cell membrane band 3. In a blind trial, all A, B and O bloodstains (a 1 cm long thread) and AB bloodstains (a 1.5 cm long thread) were accurately typed by this method. Even when bloodstains were contaminated by other body fluids (e.g., semen and saliva), only the ABO blood group epitopes on band 3 of the red cell membrane were detected. Thus, identification of human blood and ABO blood grouping of bloodstains which were contaminated by other body fluids could be simultaneously performed by this method.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431400     DOI: 10.1007/bf01642795

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  10 in total

1.  Species-specific epitopes exist on the cytoplasmic amino-terminal domain of erythrocyte band 3 protein.

Authors:  A Kimura; T Uda; S Nakashima; H Ikeda; S Yasuda; M Osawa; T Tsuji
Journal:  J Biochem       Date:  1992-08       Impact factor: 3.387

2.  ABO blood grouping of saliva from mixed body fluids by sandwich methods using monoclonal antibodies to tissue specific epitopes on blood group substance in saliva.

Authors:  A Kimura; F Matsumura; K Sodesaki; T Tsuji
Journal:  Int J Legal Med       Date:  1991       Impact factor: 2.686

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Membrane proteins related to anion permeability of human red blood cells. I. Localization of disulfonic stilbene binding sites in proteins involved in permeation.

Authors:  Z I Cabantchik; A Rothstein
Journal:  J Membr Biol       Date:  1974       Impact factor: 1.843

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Characterization of the reversible conformational equilibrium of the cytoplasmic domain of erythrocyte membrane band 3.

Authors:  P S Low; M A Westfall; D P Allen; K C Appell
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

7.  Identification of the blood-group ABH-active glycoprotein components of human erythrocyte membrane.

Authors:  J Finne
Journal:  Eur J Biochem       Date:  1980-02

8.  ABO blood grouping of semen from mixed body fluids with monoclonal antibody to tissue-specific epitopes on seminal ABO blood group substance.

Authors:  A Kimura; F Matsumura; K Sodesaki; M Osawa; H Ikeda; S Yasuda; T Tsuji
Journal:  Int J Legal Med       Date:  1991       Impact factor: 2.686

9.  The carbohydrate moiety of band 3 glycoprotein of human erythrocyte membranes. Structures of lower molecular weight oligosaccharides.

Authors:  T Tsuji; T Irimura; T Osawa
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

Review 10.  The organization of proteins in the human red blood cell membrane. A review.

Authors:  T L Steck
Journal:  J Cell Biol       Date:  1974-07       Impact factor: 10.539

  10 in total
  2 in total

Review 1.  Blood stains of the Turin Shroud 2015: beyond personal hopes and limitations of techniques.

Authors:  Giovanni Di Minno; Rosanna Scala; Itala Ventre; Giovanni de Gaetano
Journal:  Intern Emerg Med       Date:  2016-03-21       Impact factor: 3.397

2.  The applicability of ELISA detection of gastric mucosa-expressing proteins for the identification of vomit.

Authors:  Tomoko Akutsu; Hisako Saito; Hirotaro Iwase; Ken Watanabe; Ayari Takamura; Koichi Sakurada; Sachio Miyasaka
Journal:  Int J Legal Med       Date:  2016-06-27       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.